Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice

Background Growing evidences indicate that the alterations in gut microbiota are associated with the efficacy of glucocorticoids (GCs) in the treatment of systemic lupus erythematosus (SLE). However, there is no evidence to prove whether gut microbiota directly mediates the effects of GCs. Methods U...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Arthritis research & therapy Ročník 23; číslo 1; s. 1 - 10
Hlavní autoři:	Wang, Mingzhu, Zhu, Zhengyang, Lin, Xiaoying, Li, Haichang, Wen, Chengping, Bao, Jie, He, Zhixing
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BioMed Central 14.09.2021 BioMed Central Ltd Springer Nature B.V BMC
Témata:	Antibodies Arthritis Care and treatment Corticosteroids Disease Dosage and administration Drug dosages Fecal microbiota transplantation Feces Gut microbiota Health aspects Immunosuppressive agents Laboratory animals Liver Lupus Medical research Medicine Medicine & Public Health Microbiota Microbiota (Symbiotic organisms) MRL/lpr mice Orthopedics Prednisone Research Article Rheumatology Spleen Systemic lupus erythematosus Testing Tumor necrosis factor-TNF China Japan Gut microbiota Prednisone Systemic lupus erythematosus MRL/lpr mice Fecal microbiota transplantation
ISSN:	1478-6362, 1478-6354, 1478-6362
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!